Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-10

Clinical Trial Update: Safety and Efficacy of SX600 Administered by Lumbosacral Transforaminal Epidural Injection for Radicular Pain [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SX600 delivered via lumbosacral transforaminal epidural injection in lumbar radiculopathy has been terminated after Phase 1/2 with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SX600

Snippet

Sponsor: SpineThera Australia PTY LTD | Conditions: Lumbar Radiculopathy | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-01-10